Hint mode is switched on Switch off

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Cbonds API
Bring Market Data into Your Systems

Access ETF and Mutual Funds Data via API

  • Prices & NAV
  • Fund Structure
  • Inflows & dividends

Choose all Reset all
 
(%)
US78464A8707
XBI ISIN
Exchange Traded Funds (ETF)
Type of fund
SPDR State Street Global Advisors
Provider
154.81 USD
NAV per Share | 03/11/2026
31/01/2006
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Total Cost Ratio
10,550.13 mln USD
Fund NAV | 03/11/2026
10,550.13 mln USD
Share Class NAV | 03/11/2026
No
UCITS
USA
Country of registration
1 / 3 (11/09/2015)
Split

Try in 7-days Trial access

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
Unlock Data

Yield on 03/11/2026, NYSE Arca

  • YTD
    27.64 %
  • 1M
    0.35 %
  • 3M
    5.2 %
  • 6M
    18.93 %
  • 1Y
    41.65 %
  • 3Y
    118.2 %
  • 5Y
    16.24 %
  • 10Y
    194.68 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XBI)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Structure XBI on 02/11/2026

Download structure in Excel
Paper Value
MODERNA INC 2.43%
EXELIXIS INC 1.79%
HALOZYME THERAPEUTICS INC 1.79%
REGENERON PHARMACEUTICALS 1.77%
AMGEN INC 1.77%
BIOGEN INC 1.76%
UNITED THERAPEUTICS CORP 1.75%
GILEAD SCIENCES INC 1.74%
ABBVIE INC 1.71%
NATERA INC 1.71%
SPYRE THERAPEUTICS INC 1.64%
TG THERAPEUTICS INC 1.63%
VERTEX PHARMACEUTICALS INC 1.58%
ORUKA THERAPEUTICS INC 1.55%
TWIST BIOSCIENCE CORP 1.53%
ALKERMES PLC 1.47%
BRIDGEBIO PHARMA INC 1.47%
PROTAGONIST THERAPEUTICS INC 1.42%
INCYTE CORP 1.42%
NEUROCRINE BIOSCIENCES INC 1.4%
KYMERA THERAPEUTICS INC 1.38%
CRISPR THERAPEUTICS AG 1.37%
REVOLUTION MEDICINES INC 1.35%
PTC THERAPEUTICS INC 1.34%
BIOMARIN PHARMACEUTICAL INC 1.33%
GRAIL INC 1.32%
ROIVANT SCIENCES LTD 1.28%
KRYSTAL BIOTECH INC 1.27%
INSMED INC 1.26%
KODIAK SCIENCES INC 1.26%
CYTOKINETICS INC 1.25%
VAXCYTE INC 1.22%
ERASCA INC 1.19%
PRAXIS PRECISION MEDICINES I 1.18%
MADRIGAL PHARMACEUTICALS INC 1.17%
COGENT BIOSCIENCES INC 1.17%
VERACYTE INC 1.15%
DIANTHUS THERAPEUTICS INC 1.14%
CAREDX INC 1.14%
RHYTHM PHARMACEUTICALS INC 1.12%
TRAVERE THERAPEUTICS INC 1.11%
IONIS PHARMACEUTICALS INC 1.1%
ARROWHEAD PHARMACEUTICALS IN 1.07%
MIRUM PHARMACEUTICALS INC 1.06%
CG ONCOLOGY INC 0.96%
ARCUTIS BIOTHERAPEUTICS INC 0.95%
IMMUNITYBIO INC 0.94%
VIKING THERAPEUTICS INC 0.93%
ALNYLAM PHARMACEUTICALS INC 0.91%
IOVANCE BIOTHERAPEUTICS INC 0.91%
BEAM THERAPEUTICS INC 0.9%
TANGO THERAPEUTICS INC 0.89%
RELAY THERAPEUTICS INC 0.85%
ULTRAGENYX PHARMACEUTICAL IN 0.84%
CELCUITY INC 0.81%
SCHOLAR ROCK HOLDING CORP 0.79%
DYNE THERAPEUTICS INC 0.76%
RECURSION PHARMACEUTICALS A 0.64%
VIRIDIAN THERAPEUTICS INC 0.64%
IMMUNOVANT INC 0.6%
HYPERLIQUID STRATEGIES 0.59%
DENALI THERAPEUTICS INC 0.58%
BIOCRYST PHARMACEUTICALS INC 0.57%
DISC MEDICINE INC 0.57%
NURIX THERAPEUTICS INC 0.57%
BIOHAVEN LTD 0.57%
VERA THERAPEUTICS INC 0.56%
SAREPTA THERAPEUTICS INC 0.55%
SUMMIT THERAPEUTICS INC 0.54%
PALVELLA THERAPEUTICS INC 0.53%
AGIOS PHARMACEUTICALS INC 0.51%
ACADIA PHARMACEUTICALS INC 0.51%
IDEAYA BIOSCIENCES INC 0.51%
ADMA BIOLOGICS INC 0.51%
INTELLIA THERAPEUTICS INC 0.5%
REPLIMUNE GROUP INC 0.49%
SELLAS LIFE SCIENCES GROUP I 0.49%
ABSCI CORP 0.48%
UNIQURE NV 0.47%
CELLDEX THERAPEUTICS INC 0.47%
VERICEL CORP 0.45%
NOVAVAX INC 0.44%
FIRST TRACKS BIOTHERAPEU W/I 0.4%
XENCOR INC 0.39%
IMMUNOME INC 0.39%
ARCUS BIOSCIENCES INC 0.37%
NEKTAR THERAPEUTICS 0.36%
STOKE THERAPEUTICS INC 0.35%
SYNDAX PHARMACEUTICALS INC 0.34%
ANAPTYSBIO INC 0.3%
PRECIGEN INC 0.29%
ZENAS BIOPHARMA INC 0.29%
VIR BIOTECHNOLOGY INC 0.28%
MANNKIND CORP 0.26%
KURA ONCOLOGY INC 0.25%
TYRA BIOSCIENCES INC 0.25%
RIGEL PHARMACEUTICALS INC 0.24%
JADE BIOSCIENCES INC 0.24%
INHIBRX BIOSCIENCES INC 0.24%
ANNEXON INC 0.23%
Show more Hide
Other - %
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.